Voxel-based whole-brain analysis shows regional and dose-dependent effects of netoglitazone in decreasing plaque mean size. by Francesca Catto (21253435)

“…(D) Long-term treatment with a high dose of netoglitazone displays a decrease in plaque size, particularly observed in the orbital cortex, olfactory area, hippocampus, thalamus, hypothalamus, midbrain, and hindbrain regions.…”

Claudin V is decreased following infection with Mtb. by Amanda S. Latham (12093638)

“…Exposure to Mtb H37Rv and HN878 decreased claudin V expression compared to uninfected controls in the frontal cortex (E), cerebral nuclei (J), brain stem (O), thalamus (T), and hippocampus (Y). …”

ECoG timescales decrease during spatial attention. by Isabel Raposo (21615517)

“…Bottom: timescales significantly decrease during covert attention relative to the attend-out condition (two locations: <i>p</i> = 0.0244; four locations: <i>p</i> < 0.0001; mean ± SEM; whiskers indicate maximum and minimum; dots correspond to individual electrodes). …”

SBP3 KD decreases cytoadhesion of iRBCs to bovine brain endothelial cells (BBECs). by Atefeh Fathi (7370876)

Prenatal alcohol exposure (PAE) decreases brain and body weights at E14 and P0. by Danielle Sambo (6077924)

Astrocytes increase contact with vessels and expression of AQP4 following Mtb infection, which is decreased in cytosis⁺ animals. by Amanda S. Latham (12093638)

“…Decreased expression of AQP4, and endfoot contact, is found in cytosis⁺ animals in the frontal cortex (D and E), cerebral nuclei (J and K), brain stem (P and Q), thalamus (V and W) and hippocampus (BB and CC). …”

Reproducibility of response time and brain measures. by Jan Willem Koten (17743224)

Subjects:

Mean cocaine consumed (mg/kg) over 10 days. by Christopher Rowan (21499924)

Subjects:

Decreased clonogenic capacity of U87MG and U251MG glioma cells dependent on SHG-44 concentration. by Denis Mustafov (19137870)

“…<p><b>(A)</b> A significant decrease in the proliferative clonal capacity of U87MG colonies was observed with 70ΜM and 100ΜM SHG-44 treatment. …”

Acute starvation decreases the Brp::rGFP heterogeneity level among γcompartments. by Hongyang Wu (8856740)

Conditional knockout of SLAMF5 in CX3CR1^er cells attenuates EAE progression, reduces brain myeloid cell activation, and decreases T cell infiltration. by Laura Bellassen (22209109)

Mean, confidence intervals (95%) and observed difference for each factor. by Nelyane N. M. Santana (5217074)

Subjects:

Deletion of C3 and C3aR reversed <i>S. aureus</i>-induced decrease in synapse density and increase in microglial phagocytosis of synapses. by Haifang Zhang (314544)

Decreased clonogenic capacity of U87MG and U251MG GB cells following treatment with SHG-44 and cis-platin at equal concentrations. by Denis Mustafov (19137870)

“…<b>(D)</b> Similarly, U251MG cells showed significantly decreased clonogenic potential upon 100ΜM SHG-44 treatment when compared to 100ΜM cis-platin and the untreated control. …”

<i>Toxoplasma gondii</i> chronic infection decreases visceral nociceptive responses in the absence of macroscopic colonic inflammation. by Alexis Audibert (21213531)

Mod loss is associated with a reduction of central brain NBs. by Amalia S. Parra (4173004)

Subjects:

Brain acylcarnitines. by Dawn B. Lammert (21175128)

Subjects: “…oxidative phosphorylation decreased…”

Table 2_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx by Tengxiang Zhao (20749475)

“…Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.</p>…”

Table 1_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx by Tengxiang Zhao (20749475)

“…Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.</p>…”

Descriptive statistics of the mean %MVC values for each stage. by Brienna Eteson (21416834)

Subjects: